[DOI] [PubMed] [Google Scholar] 292.Xue X.C., Wu Y.J., Gao M.T., Li W.G., Zhao N., Wang Z.L., Bao C.J., Yan Z., Zhang Y.Q
Decision Framework: Who Should Defer GLP-1 Treatment and When Conversation with a Provider Matters Most Breastfeeding mothers with obesity or type 2 diabetes face difficult choices between maternal metabolic health and infant safety
It's time to move beyond the hopeful promises of the supplement aisle and into the proven, powerful world of medical weight management
The estimated treatment difference was 8.03%, and higher than the weight change difference in the non-bariatric patients treated with liraglutide, which had been reported as 4.8% in a recent systematic review and meta-analysis of randomized controlled trials [50]
Physiol Rev 48:424511 Jger R, Harris RC, Purpura M, Francaux M (2007) Comparison of new forms of creatine in raising plasma creatine levels
Both involve dysregulation of reward processing